Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GB Sciences Inc GBLX

Healthcare
GB Sciences, Inc. is a plant-inspired, biopharmaceutical research and development company. It creates patented, disease-targeted formulations of cannabis and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. (GBSGB). The primary focus for the development of its lead program has been in evaluating suitable... see more

Recent & Breaking News (GREY:GBLX)

GB Sciences Announces Outstanding Results from Preclinical Study of Its Parkinson's Disease Formulations

Canada NewsWire December 20, 2019

GB Sciences Announces the Sale of The Majority Interest in Nevada Cultivation Operations to Focus on Its First Two Cannabinoid-Based Medical Compounds for Parkinson's Disease and Neuropathic Pain

Canada NewsWire December 5, 2019

GB Sciences Closes the Sale of GB Sciences Louisiana Cannabis Business to Wellcana Plus and Retains the Benefit of IP Developed Under GB Sciences Louisiana's Master Research and Development Agreement

Canada NewsWire November 18, 2019

The Closing Date of GB Sciences' Sale of GB Sciences Louisiana LLC Is Delayed

PR Newswire November 6, 2019

GB Sciences Welcomes Esteemed Patent and Intellectual Property Attorney, Mr. Edmond DeFrank, to Its Board of Directors

PR Newswire October 31, 2019

GB Sciences' Chief Science Officer Featured on the Cover of the Marijuana Business Magazine

Canada NewsWire October 9, 2019

GB Sciences Sells Its Louisiana Medical Marijuana Business At A $32 Million Total Valuation

Canada NewsWire September 17, 2019

U.S. Drug Enforcement Agency to Expand Cannabis Research: GB Sciences Submitted One of Thirty-Three Applications to Become a DEA-Registered Cannabis Supplier to U.S. Marijuana Researchers

Canada NewsWire September 3, 2019

GB Sciences Names Darin Carpenter as Executive Vice President of Cannabis Operations

Canada NewsWire August 28, 2019

GB Sciences Prepares To Launch New Products In Louisiana With Educational Seminars For Doctors And Pharmacists

Canada NewsWire August 7, 2019

History Made! GB Sciences Louisiana Announces Medical Cannabis Products Now for Sale for First Time in State History

Canada NewsWire August 6, 2019

GB Sciences Files Novel Patent Application For Chronic Pain Treatments Based On Proprietary Cannabis-Derived Formulations

Canada NewsWire July 17, 2019

GB Sciences Obtains Exclusive License for Patented Oral Thin Film Technology Containing Cannabis and Hemp-Derived Ingredients

Canada NewsWire June 11, 2019

GBS Global Biopharma and National Research Council of Canada Begin Preclinical Studies on Chronic-Neuropathic Pain Therapies

Canada NewsWire May 28, 2019

GB Sciences Prepares to Triple Production Capabilities in Its Las Vegas Facility

PR Newswire May 14, 2019

GB Sciences Louisiana Receives All Approvals and Announces the Opening of the Full Tissue Propagation Cannabis Cultivation at LSU Agricultural Center

PR Newswire April 16, 2019

Today: GB Sciences' Use of Controlled Cultivation, Product Formulations and Research Will Be Presented by Dr. Dominick Monaco at Cannabis Conference 2019, As Featured on Cover of Cannabis Business Times

PR Newswire April 2, 2019

GB Sciences Study Shows Nevada's Cannabis Strain Names Have No Correlation to Active Ingredients

PR Newswire March 28, 2019

In Case You Missed It: GB Sciences Approved For Full Operations In Main LSU AgCenter Production Facility

PR Newswire March 26, 2019

Louisiana Agriculture Commissioner Approves GB Sciences To Begin Full Operations In Main LSU AgCenter Production Facility

PR Newswire March 22, 2019